🔗 Share this article

A shadow economy for unapproved slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Experimental Drug Acquiring Traction Online

Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning effects. Followers are encouraged to message these accounts directly for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Separately, a flourishing market exists on Telegram, where groups with thousands of members share “before and after” images, injection guides and assertions of rapid British shipping. Vendors promote the drug there before directing buyers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Healthcare Professionals Voice Worries

However, doctors and pharmacists have warned that the distribution of what is still an unapproved medication in the United Kingdom is worrisome and could lead to users administering substances of unknown origin.

Some professionals said the demand for retatrutide could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach pharmaceutical, marketing, and consumer laws, potentially leading to penalties, legal action or imprisonment.

Platform Reaction and Content Removal

Based on the social media company, the service has removed problematic material and prohibited related keywords and search suggestions. The company said it was committed to keeping the platform safe and allocating resources in strengthening enforcement strategies.

Online Marketplace Operations

Investigations also found communities with up to nine thousand members selling the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of members, filled with images of slimming results, positive testimonials and step-by-step instructions for mixing or administering at home.

Within minutes of entering one group, a vendor posted contact information, where the majority of purchases occur. The vendor sent an guidebook and promised delivery within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about weight, health issues or past usage.

Item Details and Costs

Inside these communities, messages display black plastic parcels with Royal Mail labels, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors usually priced at £160 for 20 milligrams. When asked how long a pen should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A representative for the messaging service said it regularly moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting substances they cannot confirm. Even if the science behind this drug is sound, these digital products may not contain what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the increase in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she explained.

Her staff has previously seen individuals injured by personal administration from unconfirmed sources. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly investigational substance not yet approved … may subject users to potentially significant health risks”.